Vertex Pharmaceuticals Aug 2016 - Feb 2018
Senior Director, Pharmacology
Vertex Pharmaceuticals Aug 2016 - Feb 2018
Executive Director, Biology
Vertex Pharmaceuticals Jan 1, 2009 - Aug 2016
Director, Molecular Pharmacology
Neurocrine Biosciences Mar 2004 - May 2009
Senior Director and Head, Neuroscience Bridg
Merck Aug 2000 - Oct 2003
Research Fellow, Neuropharmacology
Education:
Uc San Diego 1988 - 1994
Skills:
Neuroscience Neuropharmacology Biotechnology Molecular Pharmacology Drug Discovery Life Sciences Assay Development Drug Development Biochemistry Molecular Biology Lifesciences Medicinal Chemistry Cell Biology Immunology Clinical Development
- Boston MA, US Cynthia Barber - Wayland MA, US Francoise Berlioz-Seux - Lexington MA, US Brenda Cirincione - Newtown PA, US James Jones - Norfolk MA, US Sandra Lechner - San Diego CA, US Marco Rizzo - Guilford CT, US David Stiles - Danvers MA, US
International Classification:
A61K 31/4412 A61P 25/04
Abstract:
Provided is a method of treating or lessening the severity of pain in a subject, comprising administering to the subject a compound of formula (I), defined as described herein, or a pharmaceutically acceptable salt thereof.
Susan B. Anthony Elementary School Chicago IL 1966-1972, George M. Pullman Elementary School Chicago IL 1972-1974, St. Paul Lutheran School Dolton IL 1974-1975